VHL and renal cell carcinoma: ELOC(TCEB1)-RCC is a subtype of RCC first recognized by the World Health Organization (WHO) in 2022, molecularly characterized by the presence of TCEB1 gene mutations and the absence of VHL gene mutations (12).